{"id":54779,"date":"2023-09-20T10:03:48","date_gmt":"2023-09-20T10:03:48","guid":{"rendered":"https:\/\/medsname.com\/granicip\/"},"modified":"2026-04-30T10:24:53","modified_gmt":"2026-04-30T10:24:53","slug":"granicip","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/granicip\/","title":{"rendered":"Granicip"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Granicip?<\/h3>\n<p style=\"margin:0;\"><strong>Granicip<\/strong> obsahuje <strong>granisetron 1 mg \/ 2 mg<\/strong>, , <strong>antagonista receptoru 5-HT3 druh\u00e9 generace<\/strong> ve stejn\u00e9 t\u0159\u00edd\u011b jako ondansetron, ale s del\u0161\u00edm polo\u010dasem (~9 hodin vs 4 hodiny). Pou\u017e\u00edv\u00e1 se k prevenci <strong>chemoterapi\u00ed vyvolan\u00e9<\/strong>, <strong>radiac\u00ed vyvolan\u00e9<\/strong>, a <strong>poopera\u010dn\u00ed nevolnosti a zvracen\u00ed<\/strong>. Del\u0161\u00ed polo\u010das znamen\u00e1 jednodenn\u00ed peror\u00e1ln\u00ed nebo jednor\u00e1zovou intraven\u00f3zn\u00ed aplikaci u st\u0159edn\u011b emetogenn\u00ed chemoterapie. Vyr\u00e1b\u011bno spole\u010dnost\u00ed Cipla podle standard\u016f WHO-GMP.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f5f6f8;border:1px solid #e1e4e8;border-radius:6px;padding:14px 18px;margin:24px 0;font-size:14px;\"><strong>Pro\u010d objedn\u00e1vat z MedsBase:<\/strong> \u2714 <strong>v\u00fdrobce certifikovan\u00e9ho WHO-GMP<\/strong> \u2714 Diskr\u00e9tn\u00ed balen\u00ed \u2714 Celosv\u011btov\u00e1 doprava \u2714 <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">Ov\u011b\u0159en\u00e9 recenze z\u00e1kazn\u00edk\u016f (1 400+ z\u00e1kazn\u00edk\u016f)<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\"><strong>\u26a0\ufe0f T\u0159\u00eddn\u00ed efekt prodlou\u017een\u00ed QT intervalu.<\/strong> Granisetron, podobn\u011b jako ondansetron, zp\u016fsobuje m\u00edrn\u00e9 d\u00e1vkov\u011b z\u00e1visl\u00e9 prodlou\u017een\u00ed QT intervalu. Vyvarujte se pou\u017eit\u00ed u vrozen\u00e9ho dlouh\u00e9ho QT intervalu, hypokal\u00e9mie, hypomagnez\u00e9mie nebo p\u0159i kombinaci s dal\u0161\u00edmi l\u00e9ky prodlu\u017euj\u00edc\u00edmi QT interval (azithromycin, citalopram, methadon, antipsychotika). Kardiotoxicita je men\u0161\u00ed ne\u017e u ondansetronu a palonosetron je je\u0161t\u011b bezpe\u010dn\u011bj\u0161\u00ed, ale u pacient\u016f s vy\u0161\u0161\u00edm rizikem je rozumn\u00e9 prov\u00e9st v\u00fdchoz\u00ed EKG.<\/div>\n<h2 class=\"wp-block-heading\">Granisetron vs ondansetron \u2014 kdy zvolit granisetron<\/h2>\n<p>Ob\u011b molekuly blokuj\u00ed receptor 5-HT3 a maj\u00ed podobnou \u0161pi\u010dkovou \u00fa\u010dinnost. Klinicky v\u00fdznamn\u00e9 rozd\u00edly:<\/p>\n<ul>\n<li><strong>~1,5 hodiny; jatern\u00ed metabolismus s ~80% ren\u00e1ln\u00ed exkrec\u00ed metabolit\u016f<\/strong> granisetron ~9 h, ondansetron ~4 h. Jedna d\u00e1vka granisetronu l\u00e9pe pokryje 24hodinov\u00fd chemoterapeutick\u00fd re\u017eim.<\/li>\n<li><strong>QT sign\u00e1l:<\/strong> ondansetron m\u00e1 vy\u0161\u0161\u00ed kardi\u00e1ln\u00ed sign\u00e1l (FDA limit d\u00e1vky 16 mg IV); granisetron je st\u0159edn\u00ed; palonosetron je nej\u010dist\u0161\u00ed.<\/li>\n<li><strong>Frekvence d\u00e1vkov\u00e1n\u00ed:<\/strong> granisetron se obvykle pod\u00e1v\u00e1 jednou denn\u011b peror\u00e1ln\u011b nebo jednou IV; ondansetron se pod\u00e1v\u00e1 ka\u017ed\u00fdch 8 hodin.<\/li>\n<li><strong>Z\u00e1cpa:<\/strong> podobn\u00e1 u obou, ale o n\u011bco m\u00e9n\u011b \u010dast\u00e1 u granisetronu.<\/li>\n<li><strong>Cena:<\/strong> ondansetron je levn\u011bj\u0161\u00ed a \u0161iroce dostupn\u00fd; granisetron je preferov\u00e1n, kdy\u017e jednodenn\u00ed d\u00e1vkov\u00e1n\u00ed zjednodu\u0161uje adherenci.<\/li>\n<\/ul>\n<h3 class=\"wp-block-heading\">Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Granicip je dod\u00e1v\u00e1n z <strong>v\u00fdrobce certifikovan\u00e9ho WHO-GMP<\/strong>. Ka\u017ed\u00e1 objedn\u00e1vka je diskr\u00e9tn\u011b zas\u00edl\u00e1na po cel\u00e9m sv\u011bt\u011b a je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a> \u2014 pokud nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me zdarma. Granisetron je jednodenn\u00ed antagonista 5-HT3 volby, kdy\u017e je adherence k v\u00edced\u00e1vkov\u00e9mu re\u017eimu probl\u00e9mem, a je u\u017eite\u010dnou alternativou pro pacienty, kte\u0159\u00ed \u0161patn\u011b sn\u00e1\u0161ej\u00ed ondansetron.<\/p>\n<h2 class=\"wp-block-heading\">Mechanismus \u00fa\u010dinku<\/h2>\n<p>Granisetron je vysoce selektivn\u00ed antagonista serotoninov\u00e9ho receptoru 5-HT3 na vag\u00e1ln\u00edch aferentech (perifern\u00edch) a v chemorecep\u010dn\u00ed spou\u0161t\u011bc\u00ed z\u00f3n\u011b v oblasti postrema (centr\u00e1ln\u00ed). Chemoterapie a radiace zp\u016fsobuj\u00ed, \u017ee enterochromafinn\u00ed bu\u0148ky ve st\u0159ev\u011b uvol\u0148uj\u00ed serotonin, kter\u00fd by jinak vyvol\u00e1val zvracen\u00ed p\u0159es medul\u00e1rn\u00ed zvracovac\u00ed centrum. Blokov\u00e1n\u00edm receptoru 5-HT3 granisetron p\u0159eru\u0161uje tento sign\u00e1l jak na perifern\u00edch, tak na centr\u00e1ln\u00edch m\u00edstech. Nev\u00e1\u017ee se na receptory D2, H1, muskarinov\u00e9 ani alfa-adrenergn\u00ed \u2014 proto nedoch\u00e1z\u00ed k sedaci, extrapyramidov\u00fdm reakc\u00edm a anticholinergn\u00edm vedlej\u0161\u00edm \u00fa\u010dink\u016fm.<\/p>\n<h2 class=\"wp-block-heading\">Indikace<\/h2>\n<ul>\n<li><strong>CINV (chemoterapi\u00ed indukovan\u00e9):<\/strong> st\u0159edn\u011b a vysoce emetogenn\u00ed chemoterapie \u2014 obvykle kombinovan\u00e1 s dexamethasonem \u00b1 antagonistou NK1 (aprepitantem) u vysoce emetogenn\u00edch re\u017eim\u016f.<\/li>\n<li><strong>Radia\u010dn\u011b indukovan\u00e1 nevolnost:<\/strong> celot\u011blov\u00e1 oz\u00e1\u0159en\u00ed, vysokod\u00e1vkov\u00e9 abdomin\u00e1ln\u00ed oz\u00e1\u0159en\u00ed.<\/li>\n<li><strong>Postopera\u010dn\u00ed nauzea a zvracen\u00ed (PONV):<\/strong> jednor\u00e1zov\u00e1 IV d\u00e1vka p\u0159i indukci nebo na konci operace.<\/li>\n<li><strong>Refraktern\u00ed nauzea po chemoterapii:<\/strong> po selh\u00e1n\u00ed ondansetronu (k\u0159\u00ed\u017eov\u00e1 tolerance je ne\u00fapln\u00e1 \u2014 p\u0159ep\u00edn\u00e1n\u00ed m\u016f\u017ee zachr\u00e1nit n\u011bkter\u00e9 pacienty).<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">D\u00e1vka<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;text-align:left;\">Indikace<\/th>\n<th style=\"padding:8px;text-align:left;\">D\u00e1vka<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:8px;border-bottom:1px solid #ddd;\">CINV (peror\u00e1ln\u00ed, dosp\u011bl\u00ed):<\/td>\n<td style=\"padding:8px;border-bottom:1px solid #ddd;\">2 mg PO 1 h p\u0159ed chemoterapi\u00ed, pak 2 mg denn\u011b a\u017e 5 dn\u00ed (nebo 1 mg dvakr\u00e1t denn\u011b).<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-bottom:1px solid #ddd;\">CINV (IV):<\/td>\n<td style=\"padding:8px;border-bottom:1px solid #ddd;\">10 mcg\/kg (nebo 1 mg) IV 30 min p\u0159ed chemoterapi\u00ed, pak 2 mg denn\u011b a\u017e 5 dn\u00ed (nebo 1 mg dvakr\u00e1t denn\u011b).<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border-bottom:1px solid #ddd;\">PONV:<\/td>\n<td style=\"padding:8px;border-bottom:1px solid #ddd;\">1 mg IV p\u0159i indukci nebo na konci operace (jednor\u00e1zov\u00e1 d\u00e1vka).<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border-bottom:1px solid #ddd;\">Pediatrick\u00e9 (CINV)<\/td>\n<td style=\"padding:8px;border-bottom:1px solid #ddd;\">10\u201340 mcg\/kg IV (max. 3 mg na d\u00e1vku); pod odborn\u00fdm dohledem<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border-bottom:1px solid #ddd;\">Ren\u00e1ln\u00ed\/jatern\u00ed insuficience<\/td>\n<td style=\"padding:8px;\">Rutinn\u00ed sn\u00ed\u017een\u00ed d\u00e1vky nen\u00ed nutn\u00e9; t\u011b\u017ek\u00e1 jatern\u00ed dysfunkce m\u016f\u017ee prodlou\u017eit clearance<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<ul>\n<li><strong>Velmi \u010dast\u00e9:<\/strong> bolest hlavy (~14\u201321%), z\u00e1cpa (~3\u20139%)<\/li>\n<li><strong>\u010cast\u00e9:<\/strong> z\u00e1vrat\u011b, \u00fanava, astenie, p\u0159echodn\u00e9 zv\u00fd\u0161en\u00ed AST\/ALT, nespavost, m\u00edrn\u00e1 porucha chuti<\/li>\n<li><strong>M\u00e9n\u011b \u010dast\u00e9:<\/strong> hypertenze, hypotenze, bolesti b\u0159icha, vyr\u00e1\u017eka<\/li>\n<li><strong>Vz\u00e1cn\u00e9, ale z\u00e1va\u017en\u00e9:<\/strong> prolongace QT\/torsades de pointes, serotoninov\u00fd syndrom (s SSRI\/triptany), t\u011b\u017ek\u00e1 hypersenzitivita<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interakce l\u00e9k\u016f<\/h2>\n<ul>\n<li><strong>L\u00e9ky prodlu\u017euj\u00edc\u00ed QT interval:<\/strong> vyvarujte se soub\u011b\u017en\u00e9ho u\u017eit\u00ed s azithromycinem, fluorochinolony, citalopramem, methadonem, antipsychotiky (zejm\u00e9na u pacient\u016f s poruchou elektrolyt\u016f).<\/li>\n<li><strong>Serotonergn\u00ed l\u00e9ky<\/strong> (SSRI, SNRI, MAOI, triptany, tramadol, fentanyl, linezolid): vz\u00e1cn\u011b hl\u00e1\u0161en serotoninov\u00fd syndrom.<\/li>\n<li><strong>Siln\u00e9 induktory CYP3A4<\/strong> (rifampicin, fenytoin, karbamazepin, t\u0159ezalka te\u010dkovan\u00e1): mohou sn\u00ed\u017eit hladinu granisetronu.<\/li>\n<li><strong>Siln\u00e9 inhibitory CYP3A4<\/strong> (ketokonazol, ritonavir, klarithromycin): mohou m\u00edrn\u011b zv\u00fd\u0161it hladiny \u2014 klinick\u00fd dopad je mal\u00fd.<\/li>\n<\/ul>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Jak se Granicip li\u0161\u00ed od Ondemu (ondansetron)?<\/h3>\n<p>Oba jsou antagonist\u00e9 5-HT3, ale granisetron m\u00e1 del\u0161\u00ed polo\u010das (~9 h vs ~4 h), tak\u017ee jedin\u00e1 peror\u00e1ln\u00ed d\u00e1vka pokryje den chemoterapie. Ondansetron vy\u017eaduje d\u00e1vkov\u00e1n\u00ed ka\u017ed\u00fdch 8 hodin. Ondansetron m\u00e1 m\u00edrn\u011b vy\u0161\u0161\u00ed riziko prolongace QT a FDA stanovilo maxim\u00e1ln\u00ed jednor\u00e1zovou d\u00e1vku 16 mg IV. U nekomplikovan\u00e9 nevolnosti je ondansetron levn\u011bj\u0161\u00ed; pro adherenci b\u011bhem dne chemoterapie granisetron zjednodu\u0161uje d\u00e1vkovac\u00ed re\u017eim.<\/p>\n<h3 class=\"wp-block-heading\">Kdy za\u010dne Granicip \u00fa\u010dinkovat?<\/h3>\n<p>N\u00e1stup \u00fa\u010dinku je za 30\u201360 minut p\u0159i peror\u00e1ln\u00edm pod\u00e1n\u00ed a do 5\u201310 minut p\u0159i intraven\u00f3zn\u00edm pod\u00e1n\u00ed. Peror\u00e1ln\u00ed d\u00e1vku u\u017eijte <strong>1 hodinu p\u0159ed chemoterapi\u00ed<\/strong> pro nejlep\u0161\u00ed ochranu.<\/p>\n<h3 class=\"wp-block-heading\">Je granisetron bezpe\u010dn\u00fd v t\u011bhotenstv\u00ed?<\/h3>\n<p>Granisetron je FDA kategorie B (studie na zv\u00ed\u0159atech neprok\u00e1zaly \u0161kodlivost; omezen\u00e1 data u lid\u00ed). Pou\u017e\u00edvejte pouze u refraktern\u00ed nevolnosti vyvolan\u00e9 chemoterapi\u00ed nebo hyperemesis, kdy\u017e selhaly l\u00e9ky prvn\u00ed volby; doporu\u010duje se odborn\u00fd dohled.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017eu u\u017e\u00edvat Granicip na kinet\u00f3zu nebo t\u011bhotenskou nevolnost?<\/h3>\n<p>Ne. Granisetron je ur\u010den pouze pro nevolnost zp\u016fsobenou chemoterapi\u00ed, radioterapi\u00ed a poopera\u010dn\u00ed nevolnost. Kinet\u00f3za je histaminergn\u00ed\/cholinergn\u00ed \u2014 pou\u017eijte promethazin (Avomine), cinnarizin nebo meklozin. Prvn\u00ed volbou u t\u011bhotensk\u00e9 nevolnosti je doxylamin + B6 (Doxinate, Pregnidoxin NU).<\/p>\n<h3 class=\"wp-block-heading\">Zp\u016fsobuje Granicip sedaci?<\/h3>\n<p>Ne. Stejn\u011b jako ostatn\u00ed antagonist\u00e9 5-HT3, granisetron nezp\u016fsobuje sedaci, extrapyramidov\u00e9 reakce ani anticholinergn\u00ed vedlej\u0161\u00ed \u00fa\u010dinky. Dominantn\u00edmi vedlej\u0161\u00edmi \u00fa\u010dinky jsou bolesti hlavy a z\u00e1cpa.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017eu p\u00edt alkohol p\u0159i u\u017e\u00edv\u00e1n\u00ed Granicipu?<\/h3>\n<p>Ob\u010dasn\u00e9 mal\u00e9 mno\u017estv\u00ed pravd\u011bpodobn\u011b nezp\u016fsob\u00ed farmakologickou interakci, ale alkohol m\u016f\u017ee zhor\u0161it nevolnost a dehydrataci b\u011bhem chemoterapie \u2014 vyhn\u011bte se mu b\u011bhem aktivn\u00edch l\u00e9\u010debn\u00fdch cykl\u016f.<\/p>\n<h3 class=\"wp-block-heading\">Co kdy\u017e moje nevolnost nen\u00ed pod kontrolou?<\/h3>\n<p>P\u0159idejte dexamethason, antagonistu NK1 (aprepitant) nebo olanzapin u vysoce emetogenn\u00ed chemoterapie. P\u0159echod na jin\u00fd 5-HT3 (palonosetron) nebo t\u0159\u00eddu (D2 antagonisty) je rozumn\u00fd, kdy\u017e jedna molekula selhala.<\/p>\n<h3 class=\"wp-block-heading\">Je z\u00e1cpa probl\u00e9m?<\/h3>\n<p>Ano \u2014 z\u00e1cpa se vyskytuje a\u017e u 1 z 11 u\u017eivatel\u016f p\u0159i v\u00edcedenn\u00edm u\u017e\u00edv\u00e1n\u00ed. B\u011bhem chemoterapie udr\u017eujte hydrataci, p\u0159\u00edjem vl\u00e1kniny a profylaktick\u00e1 proj\u00edmadla (senna\/bisacodyl\/movicol).<\/p>\n<h3 class=\"wp-block-heading\">Jak se Granicip skladuje?<\/h3>\n<p>Tablety skladujte p\u0159i pokojov\u00e9 teplot\u011b (pod 30\u00b0C), chr\u00e1n\u011bn\u00e9 p\u0159ed sv\u011btlem. Uchov\u00e1vejte mimo dosah d\u011bt\u00ed. Nepou\u017e\u00edvejte po uplynut\u00ed doby pou\u017eitelnosti uveden\u00e9 na obalu.<\/p>\n<h3 class=\"wp-block-heading\">Jsou antagonist\u00e9 5-HT3 jedinou mo\u017enost\u00ed proti nevolnosti p\u0159i chemoterapii?<\/h3>\n<p>Ne. Modern\u00ed postupy l\u00e9\u010dby CINV dle doporu\u010den\u00ed kombinuj\u00ed antagonistu 5-HT3 + dexamethason + (u vysoce emetogenn\u00ed chemoterapie) antagonistu NK1 jako je aprepitant. Olanzapin je tak\u00e9 \u00fa\u010dinn\u00fd u refraktern\u00edch p\u0159\u00edpad\u016f. Samotn\u00fd antagonista 5-HT3 se pou\u017e\u00edv\u00e1 hlavn\u011b u st\u0159edn\u011b emetogenn\u00edch re\u017eim\u016f.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Dal\u0161\u00ed l\u00e9\u010dba nevolnosti<\/h3>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/ondem\/\">Ondem (ondansetron tablety)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/emeset-4-odt\/\">Emeset 4 ODT (ondansetron orodispergovateln\u00e9 tablety)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/ondem-injection\/\">Ondem injekce (ondansetron IV\/IM)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/dompewal-tablet\/\">Dompewal (domperidon \u2014 antagonista D2)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/stemetil-md\/\">Stemetil MD (prochlorperazin ODT)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/nausea-treatment\/\"><strong>Prohl\u00e9dnout v\u0161echny l\u00e9ky na nevolnost<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 L\u00e9ka\u0159sk\u00e9 upozorn\u011bn\u00ed.<\/strong> Tato str\u00e1nka slou\u017e\u00ed pouze pro informaci a nenahrazuje odbornou l\u00e9ka\u0159skou pomoc. P\u0159etrv\u00e1vaj\u00edc\u00ed zvracen\u00ed, krev ve zvratc\u00edch, siln\u00e9 bolesti b\u0159icha, p\u0159\u00edznaky dehydratace, podez\u0159en\u00ed na komplikace v t\u011bhotenstv\u00ed nebo p\u0159\u00edznaky souvisej\u00edc\u00ed s chemoterapi\u00ed vy\u017eaduj\u00ed vy\u0161et\u0159en\u00ed l\u00e9ka\u0159em.<\/div>","protected":false},"excerpt":{"rendered":"<p>Granicip (Granisetron 1 mg \/ 2 mg) \u2014 jednou denn\u011b pod\u00e1van\u00fd antagonist\u00e9 5-HT3 druh\u00e9 generace pro chemoterapii, oza\u0159ov\u00e1n\u00ed a PONV. Del\u0161\u00ed polo\u010das (~9 h) ve srovn\u00e1n\u00ed s ondansetronem.<\/p>","protected":false},"featured_media":54780,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3342,3543],"product_tag":[3781,3782],"class_list":{"0":"post-54779","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-general-health","8":"product_cat-nausea-treatment","9":"product_tag-granicip","10":"product_tag-granisetron","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/54779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=54779"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/54780"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=54779"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=54779"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=54779"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=54779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}